JP2013515032A5 - - Google Patents

Download PDF

Info

Publication number
JP2013515032A5
JP2013515032A5 JP2012545276A JP2012545276A JP2013515032A5 JP 2013515032 A5 JP2013515032 A5 JP 2013515032A5 JP 2012545276 A JP2012545276 A JP 2012545276A JP 2012545276 A JP2012545276 A JP 2012545276A JP 2013515032 A5 JP2013515032 A5 JP 2013515032A5
Authority
JP
Japan
Prior art keywords
pyridin
pyrazolo
yloxy
acetamide
ring system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012545276A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013515032A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/070260 external-priority patent/WO2011076744A1/en
Publication of JP2013515032A publication Critical patent/JP2013515032A/ja
Publication of JP2013515032A5 publication Critical patent/JP2013515032A5/ja
Pending legal-status Critical Current

Links

JP2012545276A 2009-12-21 2010-12-20 二置換ヘテロアリール縮合ピリジン類 Pending JP2013515032A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2664DE2009 2009-12-21
IN2664/DEL/2009 2009-12-21
PCT/EP2010/070260 WO2011076744A1 (en) 2009-12-21 2010-12-20 Disubstituted heteroaryl-fused pyridines

Publications (2)

Publication Number Publication Date
JP2013515032A JP2013515032A (ja) 2013-05-02
JP2013515032A5 true JP2013515032A5 (enExample) 2014-01-30

Family

ID=43640661

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012545276A Pending JP2013515032A (ja) 2009-12-21 2010-12-20 二置換ヘテロアリール縮合ピリジン類

Country Status (6)

Country Link
US (1) US8742106B2 (enExample)
EP (1) EP2516437B1 (enExample)
JP (1) JP2013515032A (enExample)
CN (1) CN102762560A (enExample)
ES (1) ES2460915T3 (enExample)
WO (1) WO2011076744A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104220065A (zh) 2012-02-07 2014-12-17 Eolas治疗公司 取代的脯氨酸/哌啶用作食欲素受体拮抗剂
US9440982B2 (en) 2012-02-07 2016-09-13 Eolas Therapeutics, Inc. Substituted prolines/piperidines as orexin receptor antagonists
BR102012024778A2 (pt) 2012-09-28 2014-08-19 Cristalia Prod Quimicos Farm Compostos heteroaromáticos; processo para preparar os compostos, composições farmacêuticas, usos e método de tratamento para as dores aguda e crônica
US10221170B2 (en) 2014-08-13 2019-03-05 Eolas Therapeutics, Inc. Difluoropyrrolidines as orexin receptor modulators
EP3954685B1 (en) 2014-12-29 2025-08-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
CN105541719B (zh) * 2016-02-03 2018-06-29 安徽工业大学 一种以乳清酸为原料制备5-氨基-1,2二氢吡唑-3-酮的方法
SMT202200323T1 (it) 2016-02-12 2022-09-14 Astrazeneca Ab Piperidine alo-sostituite come modulatori del recettore di oressina
WO2018054832A1 (en) 2016-09-22 2018-03-29 Bayer Cropscience Aktiengesellschaft Novel triazole derivatives
EP3515906A1 (en) 2016-09-22 2019-07-31 Bayer CropScience Aktiengesellschaft Novel triazole derivatives and their use as fungicides
US20200029563A1 (en) 2016-09-29 2020-01-30 Bayer Cropscience Aktiengesellschaft Novel 5-substituted imidazolylmethyldioxolane derivatives
CA3038407A1 (en) 2016-09-29 2018-04-05 Bayer Cropscience Aktiengesellschaft Novel 5-substituted imidazolylmethyl derivatives
US20200017467A1 (en) 2017-02-08 2020-01-16 Bayer Cropscience Aktiengesellschaft Novel triazole derivatives
EP3580217A1 (en) 2017-02-08 2019-12-18 Bayer Aktiengesellschaft Triazolethione derivatives
EP3580218A1 (en) 2017-02-08 2019-12-18 Bayer CropScience Aktiengesellschaft Novel triazole derivatives
KR20190115449A (ko) 2017-02-10 2019-10-11 바이엘 악티엔게젤샤프트 1-(페녹시-피리디닐)-2-(1,2,4-트리아졸-1-일)-에탄올 유도체를 포함하는 유해 미생물을 방제하기 위한 조성물
WO2020020816A1 (en) 2018-07-26 2020-01-30 Bayer Aktiengesellschaft Novel triazole derivatives
EP3867224A1 (en) * 2018-10-18 2021-08-25 Boehringer Ingelheim International GmbH Scalable synthesis of optically active 1-cyclopropylalkyl-1-amines
MX2023005073A (es) * 2020-11-02 2023-05-16 Merck Sharp & Dohme Llc Agonistas macrociclicos de los receptores de urea orexina.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2232038A1 (de) 1972-06-30 1974-01-10 Hoechst Ag 3-amino-1h-pyrazolo eckige klammer auf 3,4-b eckige klammer zu pyridine, ihre herstellung und verwendung
PT72878B (en) 1980-04-24 1983-03-29 Merck & Co Inc Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
AU2001264313A1 (en) * 2000-06-20 2002-01-02 Japan Tobacco Inc. Pyrazolopyridine compounds and use thereof as drugs
US6670364B2 (en) 2001-01-31 2003-12-30 Telik, Inc. Antagonists of MCP-1 function and methods of use thereof
US6962926B2 (en) 2001-01-31 2005-11-08 Telik, Inc. Antagonist of MCP-1 function, and compositions and methods of use thereof
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
US7601876B2 (en) * 2002-05-31 2009-10-13 Proteotech, Inc. Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis
EP1631260A2 (en) 2003-02-28 2006-03-08 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
DE102004061288A1 (de) 2004-12-14 2006-06-29 Schering Ag 3-Amino-Pyrazolo[3,4b]pyridine als Inhibitoren von Proteintyrosinkinasen, deren Herstellung und Verwendung als Arzneimittel
AR057455A1 (es) 2005-07-22 2007-12-05 Merck & Co Inc Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
EP1764099A3 (en) 2005-09-17 2007-05-09 Speedel Experimenta AG Diaminoalcohol derivatives for the treatment of Alzheimer, malaria, HIV
JP2007099640A (ja) 2005-09-30 2007-04-19 Tsumura & Co 含窒素複素環化合物、その製造方法およびそれを用いた医薬組成物
CA2647077A1 (en) * 2006-04-26 2007-11-01 Actelion Pharmaceuticals Ltd Pyrazolo-tetrahydro pyridine derivatives as orexin receptor antagonists
TW200815438A (en) 2006-06-13 2008-04-01 Bayer Schering Pharma Ag Substituted pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
EP1870410A1 (en) 2006-06-13 2007-12-26 Bayer Schering Pharma Aktiengesellschaft Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
GB0617161D0 (en) 2006-08-31 2006-10-11 Vernalis R&D Ltd Enzyme inhibitors
CA2691638A1 (en) 2007-07-03 2009-01-08 Glaxo Group Limited Piperidine derivatives useful as orexin receptor antagonists

Similar Documents

Publication Publication Date Title
JP2013515032A5 (enExample)
RU2417994C2 (ru) Производные пиразина, полезные в качестве антагонистов аденозинового рецептора
JP2013515033A5 (enExample)
JP5847087B2 (ja) オレキシン受容体調節因子としての縮合複素環式化合物
JP5759470B2 (ja) オレキシン受容体調節因子としての二置換オクタヒドロピロロ[3,4−c]ピロール
RU2326881C2 (ru) Конденсированные производные азолпиримидина, обладающие свойствами ингибитора фосфатидилинозитол-3-киназы (pi3k)
JP5852099B2 (ja) ある種のアミノ−ピリミジン、その組成物、及びそれを用いるための方法
DK3152199T3 (en) PYRAZOLE COMPOUNDS AND THEIR USE AS T-TYPE CALCIUM CHANNEL BLOCKERS
JP2013519724A5 (enExample)
JP2013520407A5 (enExample)
RU2478639C2 (ru) Трициклические спиро-производные в качестве модуляторов crth2
EA015034B1 (ru) 2-анилин-4-арилзамещенные тиазольные производные
JP2009519967A5 (enExample)
JP2006503010A5 (enExample)
AU2013273222A1 (en) Benzimidazole-proline derivatives
CN103002897A (zh) 特定氨基-哒嗪类,与其组合物,及其使用方法
JP2013515032A (ja) 二置換ヘテロアリール縮合ピリジン類
RU2016124178A (ru) Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет
AU2009288399A1 (en) Hedgehog pathway modulators
EP2601189A1 (en) N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein
JP2012525431A5 (enExample)
DE10356579A1 (de) Aminderivate
JP2016523911A5 (enExample)
AU2005289644A1 (en) Imidazo{4,5-b}pyrazinone inhibitors of protein kinases
JP2013545822A (ja) mGluR5受容体のアロステリック調節剤としての、二環式トリアゾールラクタムおよびピラゾールラクタム